Showing results (11-20 of 47) with videos related to
Sort By:
Pageof 5
Life (Basel, Switzerland)|November 27, 2024
Early Elevated Inflammatory Markers in SARS-CoV-2 Vaccinated Patients Are Associated with Reduced Mortality, Morbidity, and Lung InjuryOsama Khayat, Maamoun Basheer, Mayss Derawy, et al.World Journal of Gastroenterology|January 31, 2002
Non-imaging-guided fine-needle aspiration of liver lesions: a retrospective study of 279 patientsYeouda Edoute, Ehud Malberger, Orly Tibon-Fishe, et al.World Journal of Gastroenterology|July 26, 2006
Effect of insulin-sensitizing agents in combination with ezetimibe, and valsartan in rats with non-alcoholic fatty liver diseaseNimer Assy, Masha Grozovski, Ilana Bersudsky, et al.The Israel Medical Association Journal : IMAJ|November 27, 2022
Regen-COV-2 Antibody Cocktail Mediated Clearance of SARS-COV-2 in an Immunocompromised PatientMaamoun Basheer, Elias Saad, Faris Milhem, et al.Digestive Diseases and Sciences|April 4, 2007
Orlistat reverse fatty infiltration and improves hepatic fibrosis in obese patients with nonalcoholic steatohepatitis (NASH)Osamah Hussein, Masha Grosovski, Sorina Schlesinger, et al.Radiology|January 23, 2010
Presence of coronary plaques in patients with nonalcoholic fatty liver diseaseNimer Assy, Agness Djibre, Raymond Farah, et al.Hepatobiliary & Pancreatic Diseases International : HBPD INT|December 8, 2019
Predicting common bile duct stones by non-invasive parametersAnas Kadah, Tawfik Khoury, Mahmud Mahamid, et al.Gastroenterology Research|December 14, 2016
Approach to Solid Liver Masses in the Cirrhotic PatientNimer Assy, Najib Assy, Nir Samuel, et al.World Journal of Gastroenterology|January 31, 2002
Clinical implication of VEGF serum levels in cirrhotic patients with or without portal hypertensionNimer Assy, M Paizi, D Gaitini, et al.Digestive Diseases and Sciences|May 13, 2011
Fatty liver is associated with recurrent bacterial infections independent of metabolic syndromeWilliam Nseir, Hussein Taha, Julnar Khateeb, et al.Pageof 5